Podcasts Technology Wyss: Looking to Nature for Inspiration Bioinspired Approach to Sepsis Therapy

Bioinspired Approach to Sepsis Therapy

Published: Feb. 18, 2015, 6:32 p.m.

Wyss Institute Founding Director Don Ingber, Senior Staff Scientist Michael Super and Technology Development Fellow Joo Kang explain how they engineered the Mannose-binding lectin (MBL) protein to bind to a wide range of sepsis-causing pathogens and then safely remove the pathogens from the bloodstream using a novel microfluidic spleen-like device. More information: http://wyss.harvard.edu/viewpressrelease/166/bloodcleansing-biospleen-device-developed-for-sepsis-therapy